Research
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.
Latest stories
Research
October 15, 2026
Featured News
October 14, 2026
Cancer
October 14, 2026
Cancer
October 9, 2026
Cancer
October 6, 2026
Education
October 1, 2026
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community